This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Priscilla Agnew-Hines will never be able to forget that day in early 2020. On March 26, just weeks after Covid-19 officially became a global pandemic, her son died from an overdose. Larry, 41, was a chef, a drummer for his gospel church and the son who challenged Priscilla’s barbecue skills during summer cookouts. He also struggled with addiction.
LAS VEGAS — Downstairs was a sensory overload: Roulette wheels spun, slot-machine chimes rang, and dealers hurried to scoop up stacks of casino chips resting in front of busted blackjack hands. Many gamblers held a drink in one hand and a cigarette in the other. It was perhaps a strange setting for a conference about substance use treatment.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Millions of people around the world are living with long Covid, a medically perplexing, and potentially debilitating, condition. Rachel Hall-Clifford is one of them. As a medical anthropologist, she’s well suited to understanding long Covid. But as a mother, wife, friend, researcher, and teacher, it drags her down, just as it does so many others.
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
128
128
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
For members of a large extended Colombian family, an early Alzheimer’s diagnosis is practically a grim guarantee. But new research further supports the idea that a rare genetic mutation can delay the devastating disease’s onset. An international team of researchers identified 27 individuals within this extended family who carried both a genetic variant that guaranteed they’d develop Alzheimer’s and a single copy of the so-called Christchurch mutation.
Discover the importance of data in the process of commercialising drugs for rare diseases and how it plays a critical role in advancing treatment options for patients. Learn more about orphan diseases and drug development.
Sixty years ago this month, a courageous initiative created by civil rights activists and physicians aimed to transform the social and medical landscape of the United States by challenging segregation in the South. Called Freedom Summer, the work it began is still going on today. In 1964, Dr. Robert Smith , an architect of the U.S. community health center model, called activist Dr.
Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s next-generation capsid assembly modulator (CAM) candidate currently being developed for the treatment of chronic hepatitis B virus (HBV) infection. The post First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment appeared first on Pharmafile.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a deal to acquire two hospitals north of Charlotte, even though federal antitrust regulators, North Carolina officials, and economists were worried the deal would give Novant near-monopoly power in the region. But Novant, a nonprofit hospital system with $8 billion of revenue, decided to call off the deal mere hours after a federal court of appeals temporarily prevented Novant from buying the hospitals until the Fed
Improving maternity care is crucial, and healthtech innovations can play a significant role in enhancing maternal health outcomes. Explore how technology can revolutionise maternal care.
Pharmacies can be paid for a Pharmacy First consultation for any minor illness that is referred from a GP surgery, even if this is not covered by the seven common conditions listed in the service specification, Community Pharmacy England (CPE) has clarified. And they warned that rejecting GP referrals inappropriately ‘may affect the GP practice […] The post Claim Pharmacy First for any minor ailment GP referral, says CPE appeared first on The Pharmacist.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs.
Beacon Therapeutics initiated the final leg of the race for its lead asset, AGTC-501 (laruparetigene zovaparvovec), announcing recently that the company has treated its first patient in the pivotal trial, VISTA. Currently, the only retinitis pigmentosa therapy on the market is Spark Therapeutics’ Luxturna (voretigene neparvovec), a retinoid isomerohydrolase activator, indicated for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Orchid Pharma, a Chennai-based pharmaceutical company catering across the pharmaceutical value chain (discovery to delivery) with expertise in R&D and marketing, has announced the appointment of Chief Executive Officer (CEO), Rajnish Rohatgi. He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives, to favourably impact a key aspect of Indian public health.
MSD has announced the launch of its IDEA Studios, a new initiative led by the MSD Global Health Innovation Fund and MSD’s regional teams to fund and collaborate with entrepreneurs and early-stage companies focused on delivering transformative health care solutions. Announced at the HLTH Europe conference, MSD IDEA Studio Asia Pacific and MSD IDEA Studio Europe will combine the company’s industry-leading corporate venture arm with the health care expertise of its regional business teams.
Watch the exclusive interview with Henar Hevia and Carolyn Sousa at ASCO 2024 as they discuss the latest advancements in cancer research and treatment. Get insights and updates in this informative video.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. This was observed in individuals who had experienced a return of their cancer or who were unresponsive to standard treatments. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).
Public health officials have warned that cases of dengue fever in Europe are continuing to rise as climate change creates favourable conditions for invasive mosquitoes. Figures show that last year there were 130 cases of dengue acquired in a European country compared with 71 in 2022. Between 2020 and 2021 there were only 73 locally […] The post Warnings of rising cases of dengue fever in European countries appeared first on The Pharmacist.
In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses what to expect from Cardinal Health's biosimilars pipeline.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content